- Services
- Data Analysis services
-
Data Analysis services
-
- Meta-Analysis Research services
-
Meta-Analysis Research Services
-
- Data Collection Services
-
Data Collection Services
-
- Statistical & Biostatistics services
-
Statistical Programming & Biostatistics services
-
- Data Management Services
-
Data Management Services
-
- Research methodology services
-
Research methodology services
-
- Tool Development Services
-
Tool development services
-
- Statistical Interpretation services
-
Statistical Interpretation services
-
- Sample Size Calculation Services
-
Sample Size Calculation Services
-
- AI & ML Services
-
Artificial Intelligence and Machine Learning Services
-
- Report Generation Services
-
Report generation Services
-
- Data Analysis services
- Services
- Data Analysis services
-
Data Analysis services
-
- Meta-Analysis Research services
-
Meta-Analysis Research Services
-
- Data Collection Services
-
Data Collection Services
-
- Statistical & Biostatistics services
-
Statistical Programming & Biostatistics services
-
- Data Management Services
-
Data Management Services
-
- Research methodology services
-
Research methodology services
-
- Tool Development Services
-
Tool development services
-
- Statistical Interpretation services
-
Statistical Interpretation services
-
- Sample Size Calculation Services
-
Sample Size Calculation Services
-
- AI & ML Services
-
Artificial Intelligence and Machine Learning Services
-
- Report Generation Services
-
Report generation Services
-
- Data Analysis services
Articles
How to Model Surgeon Learning Curves in Medical Device Meta-Analysis for Swiss HTA?
Learn how to model surgeon learning curves, validate statistical models and assess clinical outcomes, budget...
Can Environmental Monitoring Trends Predict Contamination Before It Happens Under Annex 1’s Contamination Control Strategy?
Statistical methods can flag emerging cleanroom contamination risks. Explore microbial trends, early-warning signals, model validation...
No Trial Compares the Treatments Swiss Hospitals Actually Use: When Should You Use Network Meta-Analysis?
No trial compares your options? Learn when network meta-analysis gives a defensible indirect comparison for...
Single-Arm Trial, No Head-to-Head Data: Will IQWiG Accept Your Propensity-Score-Adjusted Comparison?
Can a propensity-score-adjusted external comparator support an IQWiG assessment? See the overlap, confounding and effect-size...
Facing FDA and HPRA Inspections at the Same Site: Can One Data Integrity Analysis Satisfy Part 11 and the Revised Annex 11?
See how Irish pharma sites can analyse data-integrity risks once, measure CAPA effectiveness and reuse...
How Do You Search German, French and Italian Swiss Literature Without Introducing Language Bias into Your Meta-Analysis?
Search German, French, Italian and English medical literature for Swiss meta-analyses, validate searches and assess...
Why Does Cpk Drift Go Unnoticed Until an HPRA Inspection? Multivariate SPC for Continued Process Verification
Cpk can fall while every control chart stays green. See how Cpk confidence bounds and...
Why Do Some Statistical Modifications Clear Route B in 14 Days While Others Stall Your UK Trial?
See which statistical trial modifications qualify for UK Route B, why many default to Route...
Will 30% Missing PRO Data Sink Your AMNOG Dossier? Designing Quality-of-Life Analyses IQWiG Won’t Downgrade
Learn how pharma teams can manage 30% missing PRO data and test whether AMNOG quality-of-life...
Can an International Meta-Analysis Prove “Appropriateness” for Swiss Patients? How FOPH Assesses Transferability
A pooled effect is not proof for Swiss patients. See what FOPH asks on transferability...
Why Does IQWiG Reject Subgroup Findings That the EMA Accepted? Planning Effect-Modifier Analyses for German Benefit Assessment
Learn why EMA and IQWiG assess subgroup findings differently and how pharma teams can plan...
Is Your Healthcare Service Next for FOPH Re-Evaluation? How a Meta-Analysis Can Strengthen Its Reimbursement Evidence
Learn how meta-analysis can strengthen FOPH re-evaluation evidence by quantifying treatment effects, uncertainty, heterogeneity and...